BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7936667)

  • 1. Induction of p21 (WAF-1/CIP1) during differentiation.
    Steinman RA; Hoffman B; Iro A; Guillouf C; Liebermann DA; el-Houseini ME
    Oncogene; 1994 Nov; 9(11):3389-96. PubMed ID: 7936667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    el-Deiry WS; Harper JW; O'Connor PM; Velculescu VE; Canman CE; Jackman J; Pietenpol JA; Burrell M; Hill DE; Wang Y
    Cancer Res; 1994 Mar; 54(5):1169-74. PubMed ID: 8118801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
    Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
    J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.
    Zhang W; Grasso L; McClain CD; Gambel AM; Cha Y; Travali S; Deisseroth AB; Mercer WE
    Cancer Res; 1995 Feb; 55(3):668-74. PubMed ID: 7834638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1.
    Vairapandi M; Balliet AG; Fornace AJ; Hoffman B; Liebermann DA
    Oncogene; 1996 Jun; 12(12):2579-94. PubMed ID: 8700517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53.
    Jiang H; Lin J; Su ZZ; Collart FR; Huberman E; Fisher PB
    Oncogene; 1994 Nov; 9(11):3397-406. PubMed ID: 7936668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
    Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
    Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
    Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of p21 by vitamin D(3) or vitamin K(2) leads to differentiation of p53-deficient MG-63 osteosarcoma cells.
    Zenmyo M; Komiya S; Hamada T; Hiraoka K; Kato S; Fujii T; Yano H; Irie K; Nagata K
    Hum Pathol; 2001 Apr; 32(4):410-6. PubMed ID: 11331958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype.
    Kramer DL; Chang BD; Chen Y; Diegelman P; Alm K; Black AR; Roninson IB; Porter CW
    Cancer Res; 2001 Nov; 61(21):7754-62. PubMed ID: 11691789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21(WAF1/CIP1).
    Yang F; von Knethen A; Brüne B
    J Leukoc Biol; 2000 Dec; 68(6):916-22. PubMed ID: 11129661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 controls proliferation of early B lineage cells by a p21 (WAF1/Cip1)-independent pathway.
    Hu L; Aizawa S; Tokuhisa T
    Biochem Biophys Res Commun; 1995 Jan; 206(3):948-54. PubMed ID: 7832809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
    Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
    Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
    Kralj M; Husnjak K; Körbler T; Pavelić J
    Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR; Almenara JA; Grant S
    Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium difficile toxin A-induced colonocyte apoptosis involves p53-dependent p21(WAF1/CIP1) induction via p38 mitogen-activated protein kinase.
    Kim H; Kokkotou E; Na X; Rhee SH; Moyer MP; Pothoulakis C; Lamont JT
    Gastroenterology; 2005 Dec; 129(6):1875-88. PubMed ID: 16344056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
    Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K
    Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.